找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Biopharmaceutical Manufacturing; Progress, Trends and Ralf Pörtner Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusi

[复制链接]
查看: 15243|回复: 50
发表于 2025-3-21 18:52:43 | 显示全部楼层 |阅读模式
期刊全称Biopharmaceutical Manufacturing
期刊简称Progress, Trends and
影响因子2023Ralf Pörtner
视频video
发行地址Comprehensive review of manufacturing aspects for biopharmaceuticals, including cell and gene therapy.Brings together the knowledge and experience of leading international experts from academia and in
学科分类Cell Engineering
图书封面Titlebook: Biopharmaceutical Manufacturing; Progress, Trends and Ralf Pörtner Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusi
影响因子.This volume “Cell Engineerring 11 - Biopharmaceutical Manufacturing: Progress, Trends and Challenges” is a source of the latest innovative research and technical development in biomanufacturing systems. It is organised into 2 parts: 1) Manufacturing of recombinant therapeutic proteins (e.g. therapeutic antibodies, biosimilars/biogenerics) and 2) Manufacturing aspects of cell and gene therapy. Each with selected chapters on the following topics for both up- and downstream, such as: Advanced process strategies, especially continuous manufacturing, Advanced culture techniques, especially single-use systems, Process transfer, scale-up/scale-down models, Processing advances/Manufacturing productivity/efficiency, Model-assisted process understanding and development/Digital Twins, Process controls and analytics, Quality control, Quality by design, Facility design and full-scale commercial systems, manufacturing technology innovation..The book comprises contributions of experts from academia and industry active in the field of cell culture development for the production of recombinant proteins, cell therapy and gene therapy, with consideration of Digital Twin´s and facility design. The kn
Pindex Book 2023
The information of publication is updating

书目名称Biopharmaceutical Manufacturing影响因子(影响力)




书目名称Biopharmaceutical Manufacturing影响因子(影响力)学科排名




书目名称Biopharmaceutical Manufacturing网络公开度




书目名称Biopharmaceutical Manufacturing网络公开度学科排名




书目名称Biopharmaceutical Manufacturing被引频次




书目名称Biopharmaceutical Manufacturing被引频次学科排名




书目名称Biopharmaceutical Manufacturing年度引用




书目名称Biopharmaceutical Manufacturing年度引用学科排名




书目名称Biopharmaceutical Manufacturing读者反馈




书目名称Biopharmaceutical Manufacturing读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 23:45:24 | 显示全部楼层
发表于 2025-3-22 01:14:54 | 显示全部楼层
Advances in Characterization of Industrial Bioreactors for Cell Culture Process of uses. This book chapter provides an overview of the main characterization methods for aerated stirred tank reactors in the context of cell culture processes. The methods described include mechanical power input, volumetric mass transfer, flow field, and mixing characterization. Examples are give
发表于 2025-3-22 07:56:56 | 显示全部楼层
发表于 2025-3-22 10:24:42 | 显示全部楼层
Continuous Bioprocessing for Downstreamreasing equipment footprint and increase equipment utilization. For the interested reader this chapter provides an overview over the main developments in continuous downstream processing of biopharmaceuticals and introduces the main unit operations such as continuous chromatography, continuous filtr
发表于 2025-3-22 14:38:53 | 显示全部楼层
Towards Digital Twin for Biopharmaceutical Processes: Concept and Progressopharmaceutical manufacturing field. The realization of DT could help reduce cost, improve productivity, maintain high and constant product quality, and meet Quality-by-Design (QbD) guidelines. Nonetheless, the development of DT is still at its infancy stage and an integrated DT in biopharma is rare
发表于 2025-3-22 21:00:08 | 显示全部楼层
发表于 2025-3-22 21:19:28 | 显示全部楼层
Production of Complex Proteins in Plants: From Farming to Manufacturingl host cells cannot produce complex biopharmaceuticals that require defined oligomerization or specific glycosylation profiles, and mammalian cells are unsuitable for the production of toxic proteins. These issues are readily overcome by plant cell cultures, which have the machinery required for com
发表于 2025-3-23 03:22:30 | 显示全部楼层
发表于 2025-3-23 08:59:03 | 显示全部楼层
Biopharma 4.0 for Biologics Manufacturing Under Pandemic Constraintslow doses and less side effects. Biopharma 4.0 relates to the fourth industrial revolution based on digitalization. Digitalization has reached biopharmaceutical industry along the whole development and value chain. Biologics manufacturing of such complex three-dimensional molecules in correct foldin
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-29 06:59
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表